CJC-1295
Price range: $48.00 through $62.00
CJC-1295 is a synthetic analogue used in laboratory studies involving growth-hormone–releasing hormone (GHRH) pathway models. Two research formats are available: a standard GHRH analogue and a DAC-modified version designed to evaluate extended-duration signaling behavior in controlled experimental environments. Supplied as a lyophilized powder, this material supports consistent preparation and reproducible laboratory conditions.
Lyophilized powder supplied in standard laboratory vials.
Not for injection. Not for clinical or therapeutic use.
Features:
- Two Research Formats: Standard CJC-1295 and DAC-modified CJC-1295 for comparative signaling studies.
- Laboratory-Ready Lyophilized Powder: Supports accurate measurement and controlled reconstitution.
- Stable Storage Profile: Suitable for refrigerated conditions after reconstitution.
Research Notes:
- GHRH Pathway Investigation: Utilized in model systems studying peptide–receptor activation dynamics.
- Duration-of-Action Models: DAC modification enables examination of extended peptide persistence in controlled environments.
- Comparative Studies: Allows evaluation of structural differences between DAC and non-DAC analogues within signaling research frameworks.
CJC-1295 provides researchers with a reliable tool for examining GHRH-related signaling in laboratory model systems. Store in a cool, dry place. This compound is intended solely for laboratory research use only.
🔬 Interested in the Science?
Review pathway models, structural comparisons, and analytical findings related to GHRH analogues.
🔬 Research Applications
- GHRH pathway signaling studies
- Persistence and duration-of-action peptide models
- Structure–function research comparing modified and unmodified analogues
🧪 Molecular Details
- CAS Number: 863288-34-0
- Molecular Formula: C165H271N47O46
- Molecular Weight: 3647.9 g/mol
- Form: Lyophilized Powder
- Appearance: White Powder
- Storage: Store in a cool, dry place.
| Weight | N/A |
|---|
